Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lifecore Biomedical, Inc. (LFCR) vs Siga Technologies Inc. (SIGA)

Lifecore Biomedical, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $233.5M against $162.4M — 1.4× the size. Lifecore Biomedical, Inc. grew revenue faster over the last twelve months: −10.0% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −37.5%) and the lower return on invested capital (−14.6% vs −2.80%). Across the 18 metrics below, Lifecore Biomedical, Inc. leads on 10 and Siga Technologies Inc. on 8.

Valuation

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.32 4.61 2.25
P/B n/m 1.50 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 2.73 2.45 2.56
Earnings yield (23.10%) (1.16%) (2.99%)
Free cash flow yield (3.21%) (8.29%) 0.00%

Profitability

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
Gross margin 26.86% 54.35% 53.94%
Operating margin (6.89%) (20.76%) 0.00%
Net margin (37.54%) (5.19%) 0.00%
Free cash flow margin (4.24%) (37.58%) 0.00%
Return on equity 201.15% (1.49%) (0.40%)
Return on assets (19.32%) (1.36%) (3.32%)
Return on invested capital (2.80%) (14.59%) 0.00%

Growth

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.03%) (70.13%) 10.01%
EPS growth (last fiscal year) (439.33%) (60.98%) —
Revenue growth, 5-year CAGR (4.24%) (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 11.50 0.00 0.05
Current ratio 3.87 21.72 2.31
Net debt to EBITDA (15.59) (6.39) 0.85

Dividend

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric LFCR SIGA Drug Manufacturers Specialty & Generic median
Market cap 162.39m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack